Cipla’s Goa facility receives single FDA observation following inspection

Share it

Cipla on Monday (January 20) announced that the United States Food and Drug Administration conducted an inspection of its wholly-owned subsidiary, Medispray Laboratories Private Ltd, located in Kundaim, Goa, from January 14-20, 2025. Shares of Cipla Ltd ended at ₹1,445.90, was by ₹3.45, or 0.24%, on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *